Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update
-Debuted as publicly-traded oncology company in March 2022 under symbol DRTS while raising approximately $90 million in gross proceeds-...
Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update
Alpha Tau Medical Ltd. Appoints Ruth Alon to its Board of Directors
Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination